Triple-negative breast cancers (TNBC) are characterized by the absence of estrogen, progesterone, and ERBB2 receptors, and are specifically identified as estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.